These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34179034)

  • 1. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
    Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
    Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
    Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
    Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2.
    Currier EE; Dabaja M; Jafri SM
    World J Hepatol; 2021 Sep; 13(9):1181-1189. PubMed ID: 34630884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
    Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
    Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests.
    Gan Q; Gong B; Sun M; Cao Z; Zheng Y; Zhang Y; Wen P; Shen Y; Hong L; Hou T; Jia Y; Li W; Li H; Xie Q
    Front Physiol; 2021; 12():642922. PubMed ID: 33815147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.
    Piano S; Dalbeni A; Vettore E; Benfaremo D; Mattioli M; Gambino CG; Framba V; Cerruti L; Mantovani A; Martini A; Luchetti MM; Serra R; Cattelan A; Vettor R; Angeli P;
    Liver Int; 2020 Oct; 40(10):2394-2406. PubMed ID: 32526083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
    Xu W; Huang C; Fei L; Li Q; Chen L
    Clin Interv Aging; 2021; 16():675-685. PubMed ID: 33911856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
    Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
    BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Samsky MD; Dunning A; DeVore AD; Schulte PJ; Starling RC; Tang WH; Armstrong PW; Ezekowitz JA; Butler J; McMurray JJ; Teerlink JR; Voors AA; Metra M; Mentz RJ; O'Connor CM; Patel CB; Hernandez AF
    Eur J Heart Fail; 2016 Apr; 18(4):424-32. PubMed ID: 26707029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Liver Dysfunction.
    Ibrahim N; Hosri J; Bteich Y; Dib A; Abou Rached A
    Cureus; 2022 Jan; 14(1):e21302. PubMed ID: 35186564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization.
    Bernal-Monterde V; Casas-Deza D; Letona-Giménez L; de la Llama-Celis N; Calmarza P; Sierra-Gabarda O; Betoré-Glaria E; Martínez-de Lagos M; Martínez-Barredo L; Espinosa-Pérez M; M Arbones-Mainar J
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32899640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value.
    Tokarczyk U; Kaliszewski K; Kopszak A; Nowak Ł; Sutkowska-Stępień K; Sroczyński M; Sępek M; Dudek A; Diakowska D; Trocha M; Gajecki D; Gawryś J; Matys T; Maciejiczek J; Kozub V; Szalast R; Madziarski M; Zubkiewicz-Zarębska A; Letachowicz K; Kiliś-Pstrusińska K; Matera-Witkiewicz A; Pomorski M; Protasiewicz M; Sokołowski J; Adamik B; Kujawa K; Doroszko A; Madziarska K; Jankowska EA
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features.
    Greiner KS; Rincón M; Derrah KL; Burwick RM
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2160627. PubMed ID: 36597834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey.
    Cappello M; Randazzo C; Bravatà I; Licata A; Peralta S; Craxì A; Almasio PL
    Clin Med Insights Gastroenterol; 2014; 7():25-31. PubMed ID: 24966712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.